Etidronate Disodium and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Etidronate Disodium and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: etidronate
Brand name: Didronel, Didronel IV.
Synonyms: Etidronate
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Etidronate Disodium-Insulin degludec
- Etidronate Disodium-Insulin Degludec (U-100) Prefilled Pens
- Etidronate Disodium-Insulin Degludec (U-100) Vials
- Etidronate Disodium-Insulin Degludec (U-200) Prefilled Pens
- Etidronate Disodium-Insulin degludec and liraglutide
- Etidronate Disodium-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Etidronate Oral, Intravenous
- Insulin aspart, recombinant Subcutaneous-Etodolac
- Insulin aspart, recombinant Subcutaneous-Etodolac Capsules
- Insulin aspart, recombinant Subcutaneous-Etodolac Capsules and Tablets
- Insulin aspart, recombinant Subcutaneous-Etodolac Extended-Release Tablets
- Insulin aspart, recombinant Subcutaneous-Etomidate